Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Citation: Boominathan, L., Vitamin-based therapy for Human cancers:1α,25-dihydroxyvitamin D(3) suppresses the expression of MDM4, the negative regulator of p53, via up regulation of its target gene, 5/June/2015, 12.06 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
This suggests that α,25-dihydroxyvitamin D(3), by decreasing the expression of its target gene, it may increase the expression of tumor suppressor p53. Thereby, it may inhibit cancer cell proliferation. Thus, pharmacological formulations encompassing “α,25-dihydroxyvitamin D(3) or its analogues“ may be used to inhibit the progression of tumors.
Undisclosed information: How α,25-dihydroxyvitamin D(3) increases the expression of tumor suppressor p53
Courtesy: When you cite drop us a line at email@example.com
* Research cooperation